Article

Multi-courses of Blinatumomab combined with reduced dose chemotherapy has been successfully used in chemo intolerant middle to high-risk pediatric B-ALL patients with invasive fungal disease

2025-03-18

Abstract excerpt

Invasive fungal disease (IFD) remains a challenging complication and a leading cause of death in the treatment of childhood acute leukemia (AL). Blinatumomab is a novel bispecific antibody targeting CD19, with excellent anti-tumor effects against B cell malignancies, including B cell acute lymphoblastic leukemia (B-ALL). Compared to standard chemotherapy, blinatumomab causes less immunosuppression. This article re...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 1dbd68e2-a77c-5216-940d-27e4bbf3c7d2
DOI: 10.22541/au.174227796.65816045/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Multi-courses of Blinatumomab combined with reduced dose chemotherapy has been successfully used in chemo intolerant middle to high-risk pediatric B-ALL patients with invasive fungal diseaseDOI 10.22541/au.174227796.65816045/v1Read

Leukemia burden impacts the efficacy and toxicity of blinatumomab in pediatric B-cell acute lymphoblastic leukemiaSemantic proximity Read

Tumor-intrinsic and -extrinsic determinants of response to blinatumomab in adults with B-ALL.Semantic proximity Read

Blinatumomab as maintenance therapy for pediatric acute B-lymphoblastic leukemia in the setting of asparaginase-associated pancreatitisSemantic proximity Read

Pneumocystis jiroveci pneumonia secondary to blinatumomab therapy: a case reportSemantic proximity Read

Remission induction in refractory, drug resistant pediatric PICALM::MLLT10+ B-cell acute lymphoblastic leukemia by venetoclaxSemantic proximity Read

Lineage switch under blinatumomab treatment of relapsed common acute lymphoblastic leukemia without MLL rearrangementSemantic proximity Read

Cytokine gene polymorphisms are associated with response to blinatumomab in B-cell acute lymphoblastic leukemia.Semantic proximity Read

Opportunities for immunotherapy in childhood acute myeloid leukemia.Semantic proximity Read

Lineage Conversion in Pediatric B-Cell Precursor Acute Leukemia under Blinatumomab TherapySemantic proximity Read

Factors associated with treatment response to CD19 CAR-T therapy among a large cohort of B cell acute lymphoblastic leukemia.Semantic proximity Read

Pretransplant Blinatumomab Improves Outcomes in B Cell Acute Lymphoblastic Leukemia Patients Who Undergo Allogeneic Hematopoietic Cell TransplantationSemantic proximity Read